Dengue Test Kits

AccuQuik™ is a CE, ISO, USFDA Dengue Test Kits manufacturer.
As an American brand, AccuQuik™ places the highest priority on the quality of our Dengue Test Kit products. However, as we look to serve the needs of the developing world, our test kits are manufactured in our India and China based facilities.

Dengue Test Kits

AccuQuik™ is a CE, ISO, USFDA Dengue Test Kits manufacturer.
As an American brand, AccuQuik™ places the highest priority on the quality of our Dengue Test Kit products. However, as we look to serve the needs of the developing world, our test kits are manufactured in our India and China based facilities.

Dengue Test Kits Features


Test: Dengue IgG/IgM Rapid Test Disease: Dengue Fever Specimen: Serum/Plasma, Whole Blood Test Form: Cassette, Strips
Packaging:
  • 1 strip/pack, 50 packs/box
  • 1 cassette/pack, 25 packs/box

Dengue Test Kits

Choose Specification

Dengue Test Kits

More Information about the Test and Dengue


The dengue fever diagnostic test detects two classes of antibodies, immunoglobulin G and M, in the serum/plasma or blood through the use of specific complementary antibody markers. Diagnosis may require multiple tests as the body’s immune system produces varying levels of antibodies over the course of the illness. The test will take approximately 20 minutes to provide a result.

In the case of a positive result one should consult with their doctor to consider the first stage of treatment. The dengue test has been shown to be accurate in 98% of cases, clearly demonstrating its reliability. Certain medical factors may influence the result of the test, for instance previous dengue fever infections or infection with another arbovirus. If concerned then the individual should consult a doctor before taking the test in order to ensure accurate interpretation of the results.

AccuQuik™ promotes the use of the dengue IgG/IgM rapid diagnostic test.

The Dengue Test

Available as Cassette or Strips

Dengue Test Kits Cassette and Strip Forms

The dengue fever diagnostic test detects two classes of antibodies, immunoglobulin G and M, in the serum/plasma or blood through the use of specific complementary antibody markers. Diagnosis may require multiple tests as the body’s immune system produces varying levels of antibodies over the course of the illness. The test will take approximately 20 minutes to provide a result.

In the case of a positive result one should consult with their doctor to consider the first stage of treatment. The dengue test has been shown to be accurate in 98% of cases, clearly demonstrating its reliability. Certain medical factors may influence the result of the test, for instance previous dengue fever infections or infection with another arbovirus. If concerned then the individual should consult a doctor before taking the test in order to ensure accurate interpretation of the results.

AccuQuik™ promotes the use of the dengue IgG/IgM rapid diagnostic test.

The Disease

General Information

Dengue fever is a painful and debilitating disease caused by the dengue virus. The tropical disease is transmitted by the Aedes aegypti mosquito causing a range of mild to severe symptoms. The basic symptoms include a high fever, headaches, pain behind the eyes, joint and muscle pain, nausea, vomiting, skin rash and mild nose bleeds.

As the disease progresses, a state known as dengue hemorrhagic fever develops which is associated with a high fever, bleeding nose and gums, liver enlargement, damage to lymph and blood vessels and circulatory system failure. Eventually the infected individual will encounter serious bleeding and will go into shock, followed shortly by death.

There is currently no vaccine against dengue fever however precautions can be taken to avoid contracting the disease. Preventing mosquito bites is a direct method of prevention, for example using mosquito repellant, wearing long sleeved clothes and using mosquito nets. An indirect method of
prevention is through the reduction of the mosquito population by removing breeding opportunities such as stagnant water bodies found in cans and flower pots.

Individuals with weakened immune systems are at greater risk i.e. HIV positive patients.

The incidence of dengue has increased dramatically in recent decades with over 40% of the world’s population now at risk. The disease is now endemic in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, South-east Asia and the Western Pacific.

Treatments

Visiting the doctor, resting and drinking plenty of fluids are advised. There is currently no specific medicine to treat dengue fever however pain relievers containing acetaminophen can be effective. Treatment should not include aspirin as this will worsen the bleeding.

If the patients become severely dehydrated they should be admitted to hospital where they may need to have fluids administered through a drip into the arm. Infected individuals should also take extra precaution in avoiding mosquito bites in order to help prevent the spread of the disease to others.

Around 20% of individuals infected with severe dengue die, but with access to medical care this figure can be reduced to 1%. Research investigating the forecast for dengue and its movements is ongoing, as climate change is increasing the global access of the mosquito. The WHO aims to reduce the dengue incidence by 50% by 2020.

For more information on treating dengue:
http://www.eliminatedengue.com/program

Dengue Test Kits FAQs



Do you have any other question about AccuQuik™ dengue test kits?